CDSCO regulations on pharmacovigilance in India set the legal and operational framework for detecting, assessing, and preventing adverse drug reactions (ADRs). For B.Pharm students, mastering terms like CDSCO, PvPI, Indian Pharmacopoeia Commission (IPC), ICSR, signal detection, PSUR, and MAH responsibilities is essential. These regulations connect clinical trial safety (Schedule Y), post-marketing surveillance, risk management plans (RMPs), and safety communication to protect public health. Practical knowledge of reporting pathways, Pharmacovigilance Programme of India procedures, data sources, and stakeholder roles prepares students for real-world PV tasks. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What does PvPI stand for?
- Pharmaceutical Vigilance Programme of India
- Pharmacovigilance Program of India
- Pharmacovigilance Programme of India
- Public Vigilance Program of India
Correct Answer: Pharmacovigilance Programme of India
Q2. Which body is the national regulatory authority for drugs and clinical trials in India?
- Indian Pharmacopoeia Commission (IPC)
- Central Drugs Standard Control Organization (CDSCO)
- Pharmacovigilance Programme of India (PvPI)
- World Health Organization (WHO)
Correct Answer: Central Drugs Standard Control Organization (CDSCO)
Q3. Which organization coordinates the Pharmacovigilance Programme of India (PvPI)?
- Central Drugs Standard Control Organization (CDSCO)
- Indian Pharmacopoeia Commission (IPC)
- Uppsala Monitoring Centre (UMC)
- National Institute of Virology (NIV)
Correct Answer: Indian Pharmacopoeia Commission (IPC)
Q4. What does ICSR stand for in pharmacovigilance?
- Individual Case Safety Report
- Integrated Clinical Safety Record
- International Case Safety Report
- Immediate Causality Safety Report
Correct Answer: Individual Case Safety Report
Q5. According to WHO, what is the primary aim of pharmacovigilance?
- To accelerate drug approvals
- To detect, assess, understand and prevent adverse effects
- To promote new drug marketing
- To replace clinical trials
Correct Answer: To detect, assess, understand and prevent adverse effects
Q6. Which regulatory document in India specifically covers clinical trial conduct and safety reporting?
- Pharmacopoeia of India
- Schedule Y of the Drugs and Cosmetics Rules
- Indian Medical Council Regulations
- National List of Essential Medicines
Correct Answer: Schedule Y of the Drugs and Cosmetics Rules
Q7. Which of the following best describes a SUSAR?
- Serious Unexpected Suspected Adverse Reaction
- Standard Unexpected Safety Assessment Report
- Systematic Usual Safety Adverse Record
- Suspected Usual Safety Adverse Reaction
Correct Answer: Serious Unexpected Suspected Adverse Reaction
Q8. Which stakeholders can report ADRs under the PvPI?
- Only pharmaceutical companies
- Only physicians and pharmacists
- Healthcare professionals, patients, and consumers
- Only regulatory inspectors
Correct Answer: Healthcare professionals, patients, and consumers
Q9. What is VigiBase?
- India’s national ADR database
- WHO global database of Individual Case Safety Reports maintained by UMC
- A proprietary clinical trial management system
- Indian Pharmacopoeia compilation
Correct Answer: WHO global database of Individual Case Safety Reports maintained by UMC
Q10. Which of the following is a core responsibility of a Marketing Authorization Holder (MAH) in pharmacovigilance?
- Manufacturing raw materials only
- Maintaining a pharmacovigilance system and reporting ADRs
- Conducting independent medical education only
- Approving clinical trial protocols
Correct Answer: Maintaining a pharmacovigilance system and reporting ADRs
Q11. Which event would generally be classified as a ‘serious’ adverse event?
- Transient mild headache that resolves spontaneously
- Hospitalization or prolongation of existing hospitalization
- Mild rash without treatment
- Temporary taste alteration
Correct Answer: Hospitalization or prolongation of existing hospitalization
Q12. Which document provides cumulative safety data, benefit-risk analysis, and recommended actions for a marketed medicine?
- Investigator’s Brochure
- Periodic Safety Update Report (PSUR)
- Clinical Study Protocol
- Certificate of Pharmaceutical Product
Correct Answer: Periodic Safety Update Report (PSUR)
Q13. In pharmacovigilance terminology, what is a ‘signal’?
- A confirmed causal association between drug and effect
- Information that suggests a new causal association or a new aspect of a known association
- An advertisement for a medicinal product
- A laboratory alert for batch release
Correct Answer: Information that suggests a new causal association or a new aspect of a known association
Q14. Which form or tool is commonly used by PvPI for reporting suspected ADRs?
- Suspected ADR Reporting Form of PvPI
- Schedule Y Clinical Trial Registration Form
- Drug Manufacturing Licence Application
- Patient Consent for Trial Form
Correct Answer: Suspected ADR Reporting Form of PvPI
Q15. Which center acts as the National Coordination Centre for PvPI?
- Central Drugs Laboratory
- Indian Pharmacopoeia Commission (IPC), Ghaziabad
- National Institute of Pharmaceutical Education and Research
- Medical Council of India
Correct Answer: Indian Pharmacopoeia Commission (IPC), Ghaziabad
Q16. Which international tool is commonly used by national PV centres (including PvPI) to manage ICSRs?
- VigiFlow
- MedDRA Lite
- SOP Tracker
- GMP Registry
Correct Answer: VigiFlow
Q17. Which of the following is NOT a typical component of a pharmacovigilance system?
- Signal detection and management
- Adverse event reporting and database management
- Risk management planning and communication
- Patent prosecution and intellectual property filings
Correct Answer: Patent prosecution and intellectual property filings
Q18. Which schedule/section of Indian regulations outlines safety reporting requirements for clinical trials?
- Schedule M (Good Manufacturing Practices)
- Schedule Y (Clinical Trials)
- Schedule L (Storage Conditions)
- Schedule T (Traditional Medicines)
Correct Answer: Schedule Y (Clinical Trials)
Q19. Who conducts pharmacovigilance inspections and enforcements in India?
- Indian Pharmacopoeia Commission only
- Central Drugs Standard Control Organization (CDSCO)
- State medical associations
- World Health Organization auditors
Correct Answer: Central Drugs Standard Control Organization (CDSCO)
Q20. How is an ‘unexpected’ adverse reaction defined in pharmacovigilance?
- An effect that is expected based on approved labeling
- An adverse reaction not consistent with applicable product information or labeling
- An adverse reaction that occurs in all patients
- An effect predicted during preclinical studies
Correct Answer: An adverse reaction not consistent with applicable product information or labeling
Q21. Which international body maintains VigiBase?
- Indian Pharmacopoeia Commission (IPC)
- Uppsala Monitoring Centre (UMC) for WHO
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA), USA
Correct Answer: Uppsala Monitoring Centre (UMC) for WHO
Q22. Which activity is a key task for signal management in pharmacovigilance?
- Manufacturing scale-up
- Statistical and clinical assessment of aggregated safety data
- Marketing campaign design
- Drug pricing negotiations
Correct Answer: Statistical and clinical assessment of aggregated safety data
Q23. Which of the following best describes an Individual Case Safety Report (ICSR)?
- An aggregated yearly safety report
- A single report containing details of one patient’s suspected adverse reaction
- A marketing authorization dossier
- A manufacturing batch record
Correct Answer: A single report containing details of one patient’s suspected adverse reaction
Q24. Which entity should healthcare professionals in India contact to report a suspected ADR at the national level?
- State Medical Council
- Pharmacovigilance Programme of India (PvPI) / ADR Monitoring Centres
- District Magistrate Office
- National Stock Exchange
Correct Answer: Pharmacovigilance Programme of India (PvPI) / ADR Monitoring Centres
Q25. What role can B.Pharm graduates play in pharmacovigilance?
- Only manufacturing quality control
- Identifying, documenting, reporting ADRs, and assisting in signal evaluation
- Issuing marketing authorizations
- None; PV is only for physicians
Correct Answer: Identifying, documenting, reporting ADRs, and assisting in signal evaluation
Q26. Which terminology dictionary is commonly used for coding adverse event terms in PV databases?
- MedDRA (Medical Dictionary for Regulatory Activities)
- DSM-V
- ICD-10 exclusively for PV
- ATC only
Correct Answer: MedDRA (Medical Dictionary for Regulatory Activities)
Q27. What information is essential in an ICSR?
- Patient details, suspected drug, description of ADR, outcome, and reporter information
- Only the drug batch number
- Only the manufacturer’s marketing plan
- Only the hospital address
Correct Answer: Patient details, suspected drug, description of ADR, outcome, and reporter information
Q28. Which of the following best reflects the relationship between CDSCO and PvPI?
- CDSCO is responsible for drug regulation; PvPI (coordinated by IPC) manages ADR collection and national PV activities
- PvPI is the legal regulator and CDSCO is an advisory body
- They are the same organization with different names
- Neither is involved in pharmacovigilance
Correct Answer: CDSCO is responsible for drug regulation; PvPI (coordinated by IPC) manages ADR collection and national PV activities
Q29. Which action is part of risk minimization in pharmacovigilance?
- Discontinuing all clinical trials indefinitely
- Updating product labeling, issuing safety communications, and educational programs for HCPs
- Withholding safety data from regulators
- Increasing drug prices
Correct Answer: Updating product labeling, issuing safety communications, and educational programs for HCPs
Q30. Which statement best summarizes the main objective of CDSCO pharmacovigilance regulations?
- To maximize drug sales through safety claims
- To ensure timely detection, assessment, and minimization of risks associated with medicines to protect public health
- To replace clinical pharmacology with marketing strategies
- To standardize pharmaceutical packaging design
Correct Answer: To ensure timely detection, assessment, and minimization of risks associated with medicines to protect public health
